Researchers have made a significant advancement in the fight against pancreatic cancer. A promising new experimental drug now offers hope by extending the lives of patients through the slowing of cancer progression. This development is the result of many years of dedicated research.
The drug is taken once a day and targets one of the most lethal forms of cancer. Dr. Rachna Shroff, associate director of clinical investigations at the University of Arizona Comprehensive Cancer Center, provides insights into this breakthrough. Stephanie Sy interviews Dr. Shroff to explore the potential impact of this development.
Stephanie Sy, a correspondent for PBS News Hour, has extensive experience in broadcasting. Her work spans multiple networks including ABC News, Al Jazeera America, CBSN, CNN International, and PBS News Hour Weekend. Before her current role, Sy was with Yahoo News, where she covered the 2018 Midterm Elections and reported from Donald Trump’s victory party during the 2016 election.
Leave a Reply